Reply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure

  1. Pérez-Belmonte, L.M.
  2. Miramontes-González, J.P.
  3. Osuna-Sánchez, J.
  4. Lara, J.P.
  5. Gómez-Huelgas, R.
Revue:
Journal of the American Geriatrics Society

ISSN: 1532-5415 0002-8614

Année de publication: 2022

Volumen: 70

Número: 5

Pages: 1585-1589

Type: Lettre

DOI: 10.1111/JGS.17703 GOOGLE SCHOLAR lock_openAccès ouvert editor